Healthcare · Pharmaceutical expenditure
Malaysia's pharmaceutical expenditure stands at 1.70 % GDP of GDP in 2026, ranking 36 out of 197 countries. This moderate level is typical for nations with a growing pharma sector: a large share of drugs is imported, but local generic production is on the rise. Centralized procurement by public hospitals keeps costs in check, while the private sector, especially in Kuala Lumpur and Penang, drives demand for pricier brands.
Data for 2026 · unit: % GDP
Position
#36 / 197
Malaysia world ranking
Country position on the scale from last to first place for this indicator.
MY
#36
#197#1
Trend
Change over time
Change in indicator over the available period.
0.80
1990
1.00
2000
1.30
2010
1.60
2020
1.70
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Malaysia stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Malaysia — how much?
Based on 2026 data — 1.70 % GDP. This is rank #36 out of 197 countries.
What is Malaysia's rank by Pharmaceutical expenditure?
Malaysia ranks #36 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Malaysia?
Over the available period the indicator changed from 0.80 to 1.70 % GDP.